BUSINESS NEWS
Stem Cell Firms Get Bill Activity Boost
Biotech companies that use stem cell technologies received a boost Friday after House Republican leaders said they would support a research bill that encouraged harvesting the cells from umbilical cords, in light of a presidential veto threat over a bill calling for the use of embryonic cells.
Article
Cellerant in Race to Be First to Market Stem Cell Therapy
With a new $16 million round of venture capital money in its pocket and plans for more clinical trials by the end of the year, stem cell biotechnology company Cellerant Therapeutics Inc. hopes to get one of the first commercially viable stem cell therapies on the market, possibly in the next 18 months.
Article
Cell Genesys Reports Positive Follow-Up Data From Trial of GVAX Vaccine
Cell Genesys has reported additional results from its second multicenter Phase II trial of GVAX vaccine for prostate cancer which evaluated escalating doses of the vaccine in 80 patients with advanced hormone-refractory metastatic prostate cancer.
Article
Chromos and Targeted Molecules Corporation to Merge
Chromos Molecular Systems Inc., a cellular engineering and therapeutics company, announced today that it has agreed to acquire Targeted Molecules Corporation, a biotechnology company focused on the research and development of two antibody product candidates for treatment of multiple sclerosis and acute thrombosis.
Article
CytoGenix Obtains HIV Vaccine License from NIH
CytoGenix, Inc. announced today that it has obtained a commercial evaluation license from the National Institutes of Health (NIH) for a DNA plasmid developed by scientists from the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC).
Article
Dendreon Announces Results of Provenge Study in Early-Stage Prostate Cancer
Article
Genitope Moves to Fremont
The biotechnology firm said Monday that it has signed 15-and-a-half year leases for its commercial manufacturing and new corporate headquarters in Ardenwood Technology Park in Fremont, owned by Peery-Arrillaga.
Article
GenVec Gets OK to Resume Gene Therapy Trials
GenVec, Inc. announced today that the U.S. Food and Drug Administration (FDA) informed the company that it may resume its Phase II clinical trial of TNFerade(TM) in rectal cancer.
Article
MultiCell Technologies Announces Licensing Agreement Between Bristol-Myers Squibb and MultiCell’s Licensee, Xenotech, LLC
MultiCell Technologies, Inc., a leading supplier of immortalized non-tumorigenic human hepatocytes as pharmaceutical candidate optimization tools announced today that its licensee, XenoTech, LLC, executed a three-year use and propagation agreement with pharmaceutical company Bristol-Myers Squibb.
Article
ProCord Trial for Complete Spinal Cord Injury Now Live at Shepherd Center in Atlanta
Article
TheraVitae And Chaophya Hospital Pave Way For Adult Stem Cell Therapy In Thailand
Article
MARKET REPORTS
Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer.
“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information, including order forms, please see:
Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1 Vol. 2
Cell Therapy Order Form
“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.
A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents
Immunotherapy Reports Order Form